DepoMed, Inc. (NASDAQ: DEPO) reported Q1 EPS of $0.30, $0.20 better than the analyst estimate of $0.10. Revenue for the quarter came in at $76.54 million versus the consensus estimate of $53.57 million.

For earnings history and earnings-related data on DepoMed, Inc. (DEPO) click here.